These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

797 related items for PubMed ID: 15582106

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R, Mohapel P, Brundin P, Paul G.
    Behav Brain Res; 2005 Jul 01; 162(1):1-10. PubMed ID: 15922062
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
    Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M.
    Neurosci Res; 2005 Mar 01; 51(3):299-308. PubMed ID: 15710494
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.
    Rodríguez M, Barroso-Chinea P, Abdala P, Obeso J, González-Hernández T.
    Exp Neurol; 2001 May 01; 169(1):163-81. PubMed ID: 11312569
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
    Metz GA, Piecharka DM, Kleim JA, Whishaw IQ.
    Brain Res; 2004 Nov 05; 1026(1):126-35. PubMed ID: 15476704
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST, Allbutt HN, Billing R, Radford J, Coster MJ, Kassiou M, Henderson JM.
    Brain Res Bull; 2009 Feb 16; 78(2-3):85-90. PubMed ID: 18822357
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL, Kelly AM, Kennedy GA.
    Behav Brain Res; 2008 Nov 03; 193(1):37-47. PubMed ID: 18547659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Moderate degeneration of nigral neurons after repeated but not after single intrastriatal injections of low doses of 6-hydroxydopamine in mice.
    Richter F, Hamann M, Richter A.
    Brain Res; 2008 Jan 10; 1188():148-56. PubMed ID: 18035334
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
    Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I.
    Behav Brain Res; 2004 May 05; 151(1-2):303-12. PubMed ID: 15084446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.